InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

Current share price for 4DX : $3.880 0.21 (5.72%)+

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,328 Becoming a substantial holder 26 Jun 2026 8:11AM $4.570 $3.880 fallen by 15.10%
$2,328 Becoming a substantial holder 24 Jun 2026 8:22AM $4.730 $3.880 fallen by 17.97%
$2,328 Change of Director's Interest Notice JS 23 Jun 2026 9:28AM $4.720 $3.880 fallen by 17.80%
$2,328 Ceasing to be a substantial holder 23 Jun 2026 8:14AM $4.720 $3.880 fallen by 17.80%
$2,328 Becoming a substantial holder 22 Jun 2026 8:11AM $4.540 $3.880 fallen by 14.54%
$2,328 Change in substantial holding 19 Jun 2026 5:59PM $4.540 $3.880 fallen by 14.54%
$2,328 Application for quotation of securities - 4DX 12 Jun 2026 3:55PM $3.685 $3.880 risen by 5.29%
$2,328 4DMedical targets US$2.5B PE market entry for CTVQ 2 Jun 2026 8:30AM $4.090 $3.880 fallen by 5.13%
$2,328 Proposed issue of securities - 4DX 1 Jun 2026 9:45AM $3.970 $3.880 fallen by 2.27%
$2,328 Proposed issue of securities - 4DX 1 Jun 2026 9:34AM $3.970 $3.880 fallen by 2.27%
$2,328 4DMedical creates EU platform via contextflow acquisition 1 Jun 2026 9:31AM $3.970 $3.880 fallen by 2.27%
$2,328 Application for quotation of securities - 4DX 29 May 2026 3:37PM $3.890 $3.880 fallen by 0.26%
$2,328 CTVQ enters US Outpatient Market via SimonMed 170 sites 29 May 2026 10:03AM $3.420 $3.880 risen by 13.45%
$2,328 Becoming a substantial holder 28 May 2026 5:43PM $3.340 $3.880 risen by 16.17%
$2,328 Becoming a substantial holder 27 May 2026 3:33PM $3.510 $3.880 risen by 10.54%
$2,328 Ceasing to be a substantial holder 26 May 2026 5:10PM $3.320 $3.880 risen by 16.87%
$2,328 Becoming a substantial holder 21 May 2026 5:24PM $3.270 $3.880 risen by 18.65%
$2,328 Ceasing to be a substantial holder 19 May 2026 4:02PM $3.670 $3.880 risen by 5.72%
$2,328 Major publication validates CTVQ for lung surgery 19 May 2026 9:51AM $4.000 $3.880 fallen by 3%
$2,328 Application for quotation of securities - 4DX 15 May 2026 3:46PM $4.155 $3.880 fallen by 6.62%
$2,328 Becoming a substantial holder 14 May 2026 5:42PM $3.830 $3.880 risen by 1.31%
$2,328 Ceasing to be a substantial holder 4 May 2026 4:28PM $4.090 $3.880 fallen by 5.13%
$2,328 Application for quotation of securities - 4DX 1 May 2026 3:11PM $4.080 $3.880 fallen by 4.90%
$2,328 Quarterly Activity Report and Appendix 4C 30 Apr 2026 9:23AM $4.240 $3.880 fallen by 8.49%
$2,328 Becoming a substantial holder 28 Apr 2026 3:22PM $4.710 $3.880 fallen by 17.62%

26 - 50 of 591 results

Page 2 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.